Extensively Drug-Resistant Mycobacterium tuberculosis, India
Emerging Infectious Diseases, 2007 To the Editor: India is contributing nearly one third of the world’s tuberculosis (TB) cases and has the highest rate of new TB cases (1). Prevalence of multidrug-resistant TB (MDR TB) cases is on the rise in India, and proportions of new cases of MDR TB have been observed to vary from 1.1% to 5.3% in most of the reported studies.
Rajesh Mondal, Amita Jain
doaj +3 more sources
Extensively drug-resistant tuberculosis: epidemiology and management
Clinical Epidemiology, 2014 Alberto Matteelli,1 Alberto Roggi,1 Anna CC Carvalho21Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-Infection, University of Brescia, Brescia, Italy; 2Laboratory of Innovations in Therapies, Education and ...
Matteelli A, Roggi A, Carvalho ACC
doaj +6 more sources
Extensively Drug-resistant Tuberculosis, Italy and Germany
Emerging Infectious Diseases, 2007 To the Editor: Twenty-three countries have reported >1 case of extensively drug-resistant tuberculosis (XDR TB) (1); however, information about XDR TB is still incomplete. In particular, the response of XDR TB to treatment in countries with low incidence is not known. We compared mortality rates from XDR TB with those from multidrug-resistant (MDR) TB.
Giovannittista Migliori +9 more
doaj +3 more sources
Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
Emerging Infectious Diseases, 2008 We evaluated risk factors and treatment outcomes associated with multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) in Germany in 2004–2006. In 177 (4%) of 4,557 culture-positive TB cases, Mycobacterium tuberculosis isolates
Barbara Eker +10 more
doaj +3 more sources
Increasing Drug Resistance in Extensively Drug-Resistant Tuberculosis, South Africa
Emerging Infectious Diseases, 2011 We expanded second-line tuberculosis (TB) drug susceptibility testing for extensively drug-resistant Mycobacterium tuberculosis isolates from South Africa.
N. Sarita Shah +11 more
doaj +3 more sources
Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis [PDF]
New England Journal of Medicine, 2008 Extensively drug-resistant tuberculosis has been reported in 45 countries, including countries with limited resources and a high burden of tuberculosis. We describe the management of extensively drug-resistant tuberculosis and treatment outcomes among patients who were referred for individualized outpatient therapy in Peru.A total of 810 patients were ...
Mitnick, Carole D. +26 more
openaire +5 more sources
Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3 [PDF]
, 2013 Mycobacterium tuberculosis is a major human pathogen and the causative agent for the pulmonary disease, tuberculosis (TB). Current treatment programs to combat TB are under threat due to the emergence of multi-drug and extensively-drug resistant TB.
A Hill +48 more
core +21 more sources
XDR-TB, extensively drug-resistant tuberculosis
Biomédica: revista del Instituto Nacional de Salud, 2007 Ernesto Jaramillo
doaj +5 more sources
[Extensively drug-resistant tuberculosis treated with bedaquiline]. [PDF]
Rev Esp Quimioter, 2023 López Pérez A +4 more
europepmc +3 more sources
Extensively drug-resistant tuberculosis [PDF]
Current Opinion in Infectious Diseases, 2009 To describe the origin, epidemiology, diagnosis, treatment, prevention, and control of extensively drug-resistant tuberculosis (XDR TB).XDR TB is defined as the occurrence of TB in persons whose Mycobacterium tuberculosis isolates are resistant to isoniazid and rifampin and to any fluoroquinolone and at least one of three injectable second-line drugs ...
Mandeep, Jassal, William R, Bishai
openaire +4 more sources